Literature DB >> 4559947

Studies of secretin-stimulated insulin responses in man.

R L Lerner, D Porte.   

Abstract

Recent studies have suggested that secretin, like glucose, stimulates a rapid insulin response from a small storage pool. In order to evaluate the mechanism of the secretin-stimulated insulin response, small (15 U) rapidly administered intravenous injections (pulses) of secretin were given before, during, and after a 20 hr 300 mg/min glucose infusion. Contrary to previous studies demonstrating that the acute insulin response to a small (5 g) pulse of glucose given 45 min after the start of the glucose infusion was significantly diminished compared to the response to the preinfusion pulse, the acute insulin response (2-5 min Deltaimmuno-reactive insulin muU/ml) to 15-U secretin pulses exhibited a greater than twofold increase (before: 31.1+/-15.4; during: 71.2+/-40.4, muU/ml, mean +/-SD, P < 0.02). The increased response to secretin was also found after 20 hr of continuous glucose infusion, but was not observed 1 hr after cessation of the infusion when plasma glucose levels returned to control values. Thus, this increased response to secretin was glucose dependent. Four 150-U secretin pulses given at 30 min intervals elicited progressively and significantly diminished acute insulin responses with each succeeding pulse, consistent with depletion of the small storage pool. Similar to the observation that the magnitude of the insulin response to secretin was glucose dependent, the glucose-stimulated output appeared to be secretin dependent. Thus the acute insulin response to 5 g glucose was increased after secretin pretreatment (presecretin: 34.9+/-14.8; postsecretin: 50.5+/-22.5 muU/ml. P < 0.02) which suggests that secretin may either enlarge the storage pool stimulated by glucose or increase its sensitivity. The effect of epinephrine and propranolol on acute insulin responses to secretin and glucose was also different. 15-U secretin pulses were unaffected by infusions of either epinephrine (pre: 31.6+/-17.9; during: 27.8+/-16.6 muU/ml) or propranolol (pre: 12.8+/-8.4; during: 10.7+/-5.5 muU/ml). The results of these studies indicate that although both glucose and secretin stimulate a rapid insulin response, these responses are easily differentiated. The data suggest that glucose and secretin stimulate functionally separate storage pools of insulin, but that the acute response to either stimulus is partly determined by exposure to the other.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4559947      PMCID: PMC292378          DOI: 10.1172/JCI107028

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Effect of epinephrine on insulin release in man induced by secretin.

Authors:  J K Nelson; D Rabinowitz; T J Merimee
Journal:  Nature       Date:  1967-08-19       Impact factor: 49.962

2.  Effects of secretin on insulin and glucagon in portal and peripheral blood in man.

Authors:  J Dupré; L Rojas; J J White; R H Unger; J C Beck
Journal:  Lancet       Date:  1966-07-02       Impact factor: 79.321

3.  Role of adrenergic receptors in glucose-induced insulin secretion in man.

Authors:  E Cerasi; S Effendic; R Luft
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

4.  Insulin secretion following administration of secretin in patients with diabetes mellitus.

Authors:  T Deckert
Journal:  Acta Endocrinol (Copenh)       Date:  1968-09

5.  Dynamics of insulin secretion by the perfused rat pancreas.

Authors:  D L Curry; L L Bennett; G M Grodsky
Journal:  Endocrinology       Date:  1968-09       Impact factor: 4.736

6.  [Direct stimulation of insulin secretion in vitro by scretion].

Authors:  E F Pfeiffer; M Telib; J Ammon; F Melani; H Ditschuneit
Journal:  Dtsch Med Wochenschr       Date:  1965-09-17       Impact factor: 0.628

7.  Serum insulin levels in patients with chronic pancreatitis.

Authors:  J B Rogers; J M Howard; F W Pairent
Journal:  Am J Surg       Date:  1970-02       Impact factor: 2.565

8.  An analogue computer model for the insulin response to glucose infusion.

Authors:  E Cerasi
Journal:  Acta Endocrinol (Copenh)       Date:  1967-05

9.  The gastrointestinal stimulus to insulin release. II. A dual action of secretin.

Authors:  E W Kraegen; D J Chisholm; J D Young; L Lazarus
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

10.  Insulin responses to glucose: evidence for a two pool system in man.

Authors:  D Porte; A A Pupo
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

View more
  6 in total

1.  Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system.

Authors:  Carrie Yuen Yee Cheng; Jessica Yan Shuen Chu; Billy Kwok Chong Chow
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

Review 2.  Secretin: Should we revisit its metabolic outcomes?

Authors:  D H St-Pierre; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

3.  Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis.

Authors:  E W Chideckel; J Palmer; D J Koerker; J Ensinck; M B Davidson; C J Goodner
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

4.  Effects of endogenous and exogenous secretin on plasma pancreatic polypeptide concentrations in dogs.

Authors:  F Koizumi; A Ohkawa; T Kawamura; A Ishimori; I Sasaki; J Kameyama
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

Review 5.  Central nervous system regulation of organismal energy and glucose homeostasis.

Authors:  Martin G Myers; Alison H Affinati; Nicole Richardson; Michael W Schwartz
Journal:  Nat Metab       Date:  2021-06-21

Review 6.  Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?

Authors:  Sanna Laurila; Eleni Rebelos; Miikka-Juhani Honka; Pirjo Nuutila
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-04       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.